Attila Csaba Nagy
Overview
Explore the profile of Attila Csaba Nagy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghanem A, Sipos K, Toth A, Nagy A
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076898
Head and neck cancers (HNCs) are often diagnosed late, leading to poor prognosis. Chronic inflammation, particularly periodontitis, has been linked to carcinogenesis, but systemic inflammatory markers remain underexplored. This study...
2.
Ghanem A, Faludi E, Bata R, Mezei E, Hadar V, More M, et al.
PLoS One
. 2025 Feb;
20(2):e0315689.
PMID: 39946492
Background and aim Hungary has the fifth highest cancer incidence rate in the European Union, with an age-standardized rate (ASR) of 336.7 per 100,000 according to GLOBOCAN 2022. Additionally, Hungary...
3.
Ghanem A, Toth A, Nagy A
Sci Rep
. 2025 Feb;
15(1):4230.
PMID: 39905081
Oral cancer, the 13th most common globally, is primarily squamous cell carcinoma linked to tobacco, alcohol, and HPV. Despite advances in care, it remains a major health concern due to...
4.
Tran A, Ghanem A, More M, Nagy A, Toth A
Antibiotics (Basel)
. 2025 Jan;
13(12.
PMID: 39766500
: Chronic obstructive pulmonary disease (COPD) is a global health problem and the third leading contributor to mortality worldwide. This systematic review aims to summarize the results of previous studies...
5.
Nagy A, Toth A, Bak N, Ulambayar B, Ghanem A, Sztanek F
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685552
: Sodium-glucose co-transporter 2 (SGLT-2) inhibitors, initially designed for type 2 diabetes, promote glucose excretion and lower blood glucose. Newer analogs like empagliflozin and dapagliflozin improve cardiovascular outcomes through mechanisms...
6.
Assessing the factors affecting the accessibility of primary dental care for people with haemophilia
Sipos K, Marton I, More M, Nagy A, Kiss C
Haemophilia
. 2024 Nov;
31(1):69-77.
PMID: 39604148
Introduction: Patients with haemophilia (PWH) often have difficulty accessing dental services. Aim: To determine the accessibility of dental care for PWH and to examine their perceptions of how coronavirus type-2...
7.
Orosz N, Gomori G, Battamir U, Nagy A
BMC Infect Dis
. 2024 Nov;
24(1):1268.
PMID: 39521980
Background: Severe acute respiratory infection (SARI) is a major cause for hospital admission and associated with high mortality among children worldwide. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza viruses...
8.
Ghanem A, Memon H, Nagy A
Front Oncol
. 2024 Nov;
14:1444326.
PMID: 39493458
Introduction: Oral cavity cancer (OCC), primarily oral squamous cell carcinoma (OSCC), is a growing concern in Europe, particularly among younger populations. Preventable lifestyle factors and social determinants of health contribute...
9.
Varga E, Ghanem A, Faludi E, Nguyen C, Kovacs N, Nagy A
Front Endocrinol (Lausanne)
. 2024 Sep;
15:1379127.
PMID: 39247924
Introduction: Migraine, a debilitating neurological disorder characterized by recurrent headaches, affects over 1.1 billion individuals globally. Diabetes mellitus (DM), a chronic metabolic condition marked by high blood sugar levels, affects...
10.
Peto A, Toth L, Hernyak M, Lorincz H, Molnar A, Nagy A, et al.
PLoS One
. 2024 Jul;
19(7):e0306482.
PMID: 38959204
Distal sensorimotor polyneuropathy (DSPN) is the earliest detectable and the most frequent microvascular complication in diabetes mellitus. Several studies have previously demonstrated correlations between cardiovascular risk factors in diabetic patients...